HIV/AIDS

The latest HIV/AIDS news from UNC Health Care and the UNC School of Medicine.

Maternal, infant antiretrovirals prevent breast milk HIV transmission

Maternal, infant antiretrovirals prevent breast milk HIV transmission

Each year about 200,000 infants worldwide become infected with HIV through breastfeeding, and in the developing world infant formula is both prohibitively expensive and associated with increased infant deaths.

Maternal, infant antiretrovirals prevent breast milk HIV transmission - Read More…

Preventing HPV might lower risk of HIV infection in men

Men infected with human papillomavirus (HPV) are at greater risk of becoming infected with human immunodeficiency virus (HIV) than men who are not HPV positive, according to researchers at the University of North Carolina at Chapel Hill.

Preventing HPV might lower risk of HIV infection in men - Read More…

Preventing HPV might lower risk of HIV infection in men

Men infected with human papillomavirus (HPV) are at greater risk of becoming infected with human immunodeficiency virus (HIV) than men who are not HPV positive, according to researchers at the University of North Carolina at Chapel Hill.

Preventing HPV might lower risk of HIV infection in men - Read More…

UNC infectious disease fellow awarded minority scholarship to join domestic battle against the spread of HIV

Yvonne Carter, MD, is one of six scholars from under-represented minority communities to be awarded funding for HIV prevention research from the HIV Prevention Trials Network (HPTN).

UNC infectious disease fellow awarded minority scholarship to join domestic battle against the spread of HIV - Read More…

UNC infectious disease fellow awarded minority scholarship to join domestic battle against the spread of HIV

Yvonne Carter, MD, is one of six scholars from under-represented minority communities to be awarded funding for HIV prevention research from the HIV Prevention Trials Network (HPTN).

UNC infectious disease fellow awarded minority scholarship to join domestic battle against the spread of HIV - Read More…

Triangle Dance Festival for AIDS March 19 - RSVP Requested

Triangle Dance Festival for AIDS March 19 - RSVP Requested

The fifth annual Triangle Dance Festival for AIDS presents an evening of performing arts to promote community involvement and benefit local and global AIDS charities. The dance festival will be held Friday, March 19, at 7:30 p.m. in Memorial Hall.

Triangle Dance Festival for AIDS March 19 - RSVP Requested - Read More…

Triangle Dance Festival for AIDS March 19 - RSVP Requested

Triangle Dance Festival for AIDS March 19 - RSVP Requested

The fifth annual Triangle Dance Festival for AIDS presents an evening of performing arts to promote community involvement and benefit local and global AIDS charities. The dance festival will be held Friday, March 19, at 7:30 p.m. in Memorial Hall.

Triangle Dance Festival for AIDS March 19 - RSVP Requested - Read More…

PrEP treatment prevented HIV transmission in humanized mice

Systemic pre-exposure administration of antiretroviral drugs provides protection against intravenous and rectal transmission of HIV in mice with human immune systems, according to a new study published January 21, 2010 in the online journal PLoS ONE.

PrEP treatment prevented HIV transmission in humanized mice - Read More…

PrEP treatment prevented HIV transmission in humanized mice

Systemic pre-exposure administration of antiretroviral drugs provides protection against intravenous and rectal transmission of HIV in mice with human immune systems, according to a new study published January 21, 2010 in the online journal PLoS ONE.

PrEP treatment prevented HIV transmission in humanized mice - Read More…

NIAID grant launches Kashuba's plan for HIV-prevention trials

Development of an AIDS vaccine is struggling. Topical treatments aimed at stopping HIV have made little progress. Angela Kashuba, PharmD, believes that antiretroviral drugs are the best hope for halting the spread of AIDS, especially in the developing world.

NIAID grant launches Kashuba's plan for HIV-prevention trials - Read More…

NIAID grant launches Kashuba's plan for HIV-prevention trials

Development of an AIDS vaccine is struggling. Topical treatments aimed at stopping HIV have made little progress. Angela Kashuba, PharmD, believes that antiretroviral drugs are the best hope for halting the spread of AIDS, especially in the developing world.

NIAID grant launches Kashuba's plan for HIV-prevention trials - Read More…

UNC researcher: Racial disparities in HIV infection rate are ‘indictment’ of U.S. response to epidemic

UNC's Dr. Adaora A. Adimora and her fellow researchers examine factors responsible for the stark racial disparities in HIV infection in the U.S. and the now concentrated epidemic among African Americans.

UNC researcher: Racial disparities in HIV infection rate are ‘indictment’ of U.S. response to epidemic - Read More…

UNC researcher: Racial disparities in HIV infection rate are ‘indictment’ of U.S. response to epidemic

UNC's Dr. Adaora A. Adimora and her fellow researchers examine factors responsible for the stark racial disparities in HIV infection in the U.S. and the now concentrated epidemic among African Americans.

UNC researcher: Racial disparities in HIV infection rate are ‘indictment’ of U.S. response to epidemic - Read More…

UNC study will test therapies to eradicate HIV infection—medicine’s holy grail

Researchers from the UNC Institute for Global Health & Infectious Diseases have received $2.7 million from the National Institutes of Health to develop and test new therapeutic agents that may eradicate HIV infection.

UNC study will test therapies to eradicate HIV infection—medicine’s holy grail - Read More…

UNC study will test therapies to eradicate HIV infection—medicine’s holy grail

Researchers from the UNC Institute for Global Health & Infectious Diseases have received $2.7 million from the National Institutes of Health to develop and test new therapeutic agents that may eradicate HIV infection.

UNC study will test therapies to eradicate HIV infection—medicine’s holy grail - Read More…

UNC researchers decode structure of an entire HIV genome

The structure of an entire HIV genome has been decoded for the first time by researchers at UNC-Chapel Hill. The results have widespread implications for understanding the strategies that viruses, like the one that causes AIDS, use to infect humans.

UNC researchers decode structure of an entire HIV genome - Read More…

UNC researchers decode structure of an entire HIV genome

The structure of an entire HIV genome has been decoded for the first time by researchers at UNC-Chapel Hill. The results have widespread implications for understanding the strategies that viruses, like the one that causes AIDS, use to infect humans.

UNC researchers decode structure of an entire HIV genome - Read More…

Share This: